FacebookTwitterYoutubeInstagramGoogle Plus

RESISTANCE IS (NOT) FUTILE: The End of Antibiotics and the Future of Fighting Infections

Saturday, June 2, 2018
6:00 pm - 7:30 pm EST

In the race to keep up with harmful bacteria as they continually evolve to outsmart our antibiotics, we have fallen woefully behind. There are already superbugs we cannot defeat. And at the current pace, the Age of Antibiotics will end in our lifetimes. Childbirth, surgery, even small cuts will once again carry deadly risk. Predictions are by 2050 there will be more deaths from infections than from cancer if we don’t solve this crisis. Scientists are not standing idly by. Join immunologists, biologists, and infectious disease specialists to explore some exciting new tools that may be our salvation in the battle against superbugs.

The Big Ideas Series is supported in part by the John Templeton Foundation.


Carl ZimmerJournalist, Author

Carl Zimmer is an award-winning columnist for the New York Times and the author of 13 books about science. His reporting has earned awards from the National Academies of Science, the American Association for the Advancement of Sciences, and the Online Journalism Association.

Read More


Janelle S. AyresMolecular Physiologist

Janelle Ayres is an Associate Professor in the Nomis Center for Immunobiology and Microbial Pathogenesis at The Salk Institute for Biological Studies. Her pioneering research on host-pathogen interactions is redefining our definition of health.

Read More
Martin BlaserPHYSICIAN

Martin Blaser is the Singer Professor of Medicine, Professor of Microbiology, and Director of the Human Microbiome Program at NYU School of Medicine. He served as Chair, Department of Medicine from 2000-2012. A physician and microbiologist, Dr. Blaser studies the relationships we have with our persistently colonizing bacteria.

Read More
Sean BradyChemist

Sean Brady graduated with a degree in molecular biology from Pomona College in Claremont, California and received his Ph.D. in organic chemistry from Cornell University. he later moved to Harvard Medical School as a fellow in the Institute of Chemistry and Cell Biology and was named an instructor in the department of biological chemistry and molecular pharmacology at Harvard Medical School.

Read More
Vincent A. FischettiResearch Scientist

Vincent A. Fischetti Ph.D. is Professor and Head of the Laboratory of Bacterial Pathogenesis and Immunology at the Rockefeller University in New York. Fischetti’s research has focused on developing alternative methods to control bacterial infections.

Read More
Jo HandelsmanMicrobiologist

Jo Handelsman is the Director of the Wisconsin Institute for Discovery at the University of Wisconsin-Madison, as well as a Vilas Research Professor and Howard Hughes Medical Institute Professor. She is responsible for groundbreaking studies in microbial communication and work in the field of metagenomics.

Read More